BTCA — Bactolac Pharmaceutical Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesMid Cap

Annual cashflow statement for Bactolac Pharmaceutical, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	C2001 September 30th	2002 September 30th	R2003 September 30th	2004 September 30th	2005 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10KSB	10KSB
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.981	-2.16	1.94	4.24	1.88
Depreciation
Deferred Taxes
Non-Cash Items	2.64	1.59	-0.951	-0.238	0.004
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.683	-1.64	-0.541	-0.891	-0.223
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	3.18	-1.46	0.668	2.1	2.92
Capital Expenditures	-0.807	-0.308	-0.386	-0.243	-0.661
Purchase of Fixed Assets
Other Investing Cash Flow Items	0.065	0.611	0.414	3.39	-1.3
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	-0.742	0.303	0.028	3.15	-1.96
Financing Cash Flow Items	1.25	0	-0.091	-4.34	-0.118
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2.35	1.17	-0.371	-4.51	-2.07
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.085	0.011	0.326	0.743	-1.11